14th PACTRIMS Congress 2022

amy quek Photo

Welcome Note  

Dear Friends and Colleagues,

We would like to welcome you to the 14th Congress of the Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS) that will take place in Singapore from 24 to 26 November 2022.

PACTRIMS is an annual event that aims to provide clinical and scientific updates in the care of patients with multiple sclerosis (MS), neuromyelitis optica and related conditions in the Asia-Pacific region. Patients in this region face different challenges where clinical care could vary depending on different healthcare reimbursements, perceptions of disease and accessibility to diagnostic assays and medications. PACTRIMS 2022 strives to provide opportunities for participants representing their MS communities to exchange knowledge, acquire skills, share experiences, foster collaborations and work towards our shared vision of improving the care and lives of patients with MS and other CNS inflammatory demyelinating diseases. 

Singapore is privileged to host PACTRIMS this year. We are excited that we are once again able to organize an in-person meeting for our community to meet, build networks and share knowledge and ideas. It gives me great pleasure to welcome our delegates to enjoy not just the conference, but also the many sights, attractions, and cuisines that Singapore has to offer.  

On behalf of the organizing committee, we welcome you and wish you a fruitful congress in Singapore.

 

Yours sincerely,

Amy Quek May Lin

Chair, Local Organising Committee

 

SAVE-THE-DATE!  Registration will open soon.

Our 14th PACTRIMS Congress returns to a physical face-to-face meeting this year.  It will be held in Singapore from 24-26 November 2022 at the Shangri-la Hotel.  

The themes for this year's congress are:

1. NMO and MOGAD - state of the art

2. Neurodegeneration in MS: from pathophysiology to treatment

3. Infection, immunology and inflammatory demyelination: at the crossroads

4. CNS inflammation at the extremes of age - special considerations

 

More information will be updated soon.  Follow us on Facebook to get the latest and most updated information.